De novo tacrolimus-based immunosuppression reduces renal allograft fibrosis compared to neoral:: a prospective randomized clinical trial

被引：0
|
作者：
Murphy, GJ [1 ]
Waller, JR [1 ]
Sandford, R [1 ]
Nicholson, ML [1 ]
机构：
[1] Univ Leicester, Leicester Gen Hosp, Dept Surg, Leicester LE5 4PW, Leics, England
来源：
BRITISH JOURNAL OF SURGERY | 2002年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [41] Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND Study
    Friman, Styrbjorn
    Tisone, Giuseppe
    Nevens, Frederik
    Lehner, Frank
    Santaniello, Walter
    Bechstein, Wolf O.
    Zhuvarel, Sergey, V
    Isoniemi, Helena
    Rummo, Oleg O.
    Klempnauer, Juergen
    Anaokar, Swapneel
    Hurst, Martin
    Kazeem, Gbenga
    Undre, Nasrullah
    Trunecka, Pavel
    TRANSPLANTATION DIRECT, 2021, 7 (08): : E722
  • [42] Rationale and design of the OPTIMIZE trial: OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients
    S. E. de Boer
    J. S.F. Sanders
    F. J. Bemelman
    M. G.H. Betjes
    J. G.M. Burgerhof
    L. Hilbrands
    D. Kuypers
    B. C. van Munster
    S. A. Nurmohamed
    A. P.J. de Vries
    A. D. van Zuilen
    D. A. Hesselink
    S. P. Berger
    BMC Nephrology, 22
  • [43] Long-term, prolonged-release tacrolimus-based immunosuppression in de novo kidney transplant recipients: 5-year prospective follow-up of the ADHERE study patients
    Rummo, Oleg
    Carmellini, Mario
    Kamar, Nassim
    Durrbach, Antoine
    Mousson, Christiane
    Caputo, Flavia
    Mathe, Zoltan
    Christiaans, Maarten H. L.
    Kuypers, Dirk R. J.
    Klempna, Juergen uer
    Anaokar, Swapneel
    Hurst, Martin
    Kazeem, Gbenga
    Undre, Nasrullah
    Lehner, Frank
    TRANSPLANT INTERNATIONAL, 2020, 33 (02) : 161 - 173
  • [44] Long-term Prolonged-release Tacrolimus-based Immunosuppression in De Novo Kidney Transplant Recipients: 5-Y Prospective Follow-up of Patients in the ADVANCE Study
    Pernin, Vincent
    Glyda, Maciej
    Viklicky, Ondrej
    Lohmus, Aleksander
    Wennberg, Lars
    Witzke, Oliver
    von Zur-Muhlen, Bengt
    Anaokar, Swapneel
    Hurst, Martin
    Kazeem, Gbenga
    Undre, Nasrullah
    Kuypers, Dirk R. J.
    TRANSPLANTATION DIRECT, 2023, 9 (03): : E1432
  • [45] Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: Results of a prospective, randomized trial
    Neuhaus, P
    Klupp, J
    Langrehr, JM
    Neumann, U
    Gebhardt, A
    Pratschke, J
    Tullius, SG
    Lohmann, R
    Radke, C
    Rayes, N
    Neuhaus, R
    Bechstein, WO
    TRANSPLANTATION, 2000, 69 (11) : 2343 - 2353
  • [46] Pharmacokinetics and Clinical Outcomes of Generic Tacrolimus (Hexal) Versus Branded Tacrolimus in De Novo Kidney Transplant Patients: A Multicenter, Randomized Trial
    Arns, Wolfgang
    Huppertz, Andrea
    Rath, Thomas
    Ziefle, Stephan
    Rump, Lars C.
    Hansen, Anita
    Budde, Klemens
    Lehner, Lukas J.
    Shipkova, Maria
    Baeumer, Daniel
    Kroeger, Irena
    Sieder, Christian
    Klein, Thomas
    Schenker, Peter
    TRANSPLANTATION, 2017, 101 (11) : 2780 - 2788
  • [47] An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
    Sommerer, Claudia
    Suwelack, Barbara
    Dragun, Duska
    Schenker, Peter
    Hauser, Ingeborg A.
    Witzke, Oliver
    Hugo, Christian
    Kamar, Nassim
    Merville, Pierre
    Junge, Martina
    Thaiss, Friedrich
    Nashan, Bjoern
    Almartine, Eric
    Dantal, Jacques
    Dragun, Duska
    Feldkamp, Thorsten
    Hauser, Ingeborg A.
    Hazzan, Marc
    Heyne, Nils
    Hugo, Christian
    Kamar, Nassim
    Lang, Philippe
    Lehner, Frank
    Le Meur, Yannick
    Lutz, Jens
    Merville, Pierre
    Morelon, Emmanuel
    Moulin, Bruno
    Mousson, Christiane
    Muehlfeld, Anja
    Nashan, Bjorn
    Pisarski, Przemyslaw
    Rondeau, Eric
    Schenker, Peter
    Sommerer, Claudia
    Suwelack, Barbara
    Thaiss, Friedrich
    Thierry, Antoine
    Wiesener, Michael
    Witzke, Oliver
    KIDNEY INTERNATIONAL, 2019, 96 (01) : 231 - 244
  • [48] A Pilot Randomized Controlled Trial of De Novo Belatacept-based Immunosuppression After Lung Transplantation
    Huang, Howard J.
    Schechtman, Kenneth
    Askar, Medhat
    Bernadt, Cory
    Mitter, Brigitte
    Dore, Peter
    Goodarzi, Ahmad
    Yau, Simon
    Youssef, J. Georges
    Witt, Chad A.
    Byers, Derek E.
    Vazquez-Guillamet, Rodrigo
    Halverson, Laura
    Nava, Ruben
    Puri, Varun
    Kreisel, Daniel
    Gelman, Andrew E.
    Hachem, Ramsey R.
    TRANSPLANTATION, 2024, 108 (03) : 777 - 786
  • [49] TAILORED IMMUNOSUPPRESSION IN DE NOVO RENAL TRANSPLANTATION BASED ON IMMUNE FUNCTION MONITORING: A RANDOMISED CONTROLLED TRIAL
    Van Laecke, Steven
    Terryn, Wim
    Nagler, Evi
    Van Biesen, Wim
    Glorieux, Griet
    Schepers, Eva
    Vanholder, Raymond
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 406 - 406
  • [50] TWO-YEAR OBSERVATION OF A RANDOMIZED TRIAL ON TACROLIMUS-BASED THERAPY WITH WITHDRAWAL OF STEROIDS OR MYCOPHENOLATE MOFETIL AFTER RENAL TRANSPLANTATION
    Qing-guo Zhu
    ChineseMedicalSciencesJournal, 2008, 23 (04) : 244 - 248
12345